Answer:
Ask the people what food they ate and find out who else ate the same thing.
Explanation:
Social-conflict analysis points out that the social standing of drug users exists corresponding to how severely our society punishes illegal drug use.
<h3>What is social-conflict analysis?</h3>
A framework for developing theory that sees society as an arena of inequality that breeds conflict and change is the social conflict approach. Sociologists investigate the ongoing struggle between more disadvantaged and dominant groups using the social conflict approach. According to the conflict theory, which was first put forth by Karl Marx, society is constantly at war with one another over scarce resources. According to conflict theory, dominance and power, not agreement and conformity, preserve social order.
Conflict in society arises when people compete for control or authority. When two or more people disagree with one another in social interactions and each uses reciprocal social power in an effort to advance opposing but prevent the other from advancing their own goals, social conflict results.
Hence, Social-conflict analysis points out that the social standing of drug users exists corresponding to how severely our society punishes illegal drug use.
To learn more about social-conflict analysis refer to:
brainly.com/question/549714
#SPJ4
Answer:
I believe it is C. Glucose
Explanation:
Hope my answer has helped you and if not i'm sorry.
Answer:
1 tablet and a half.
Explanation:
1 mg is equivalent to 1/60gr
or
1 gr is equivalent to 60 mg.
Since you need to give 1/4 gr of morphine sulfate, you need to give 1/4 of 60mg. If you will calculate that, you will need to give 15 mg of morphine sulfate. Since the tablets come in 10 mg, you will need to give 1 tablet and a half.
You can also compute it this way:
Answer:
The arguments for the Compassionate Use Act include the following:
1. The patient has an acute disease or health condition. Also, whose life is being threaten.
2. The patient is not allowed to enter a clinical trial.
3. The patient benefit supports the potential risks of treatment.
4. The patient has no other treatment therapy for the disease or health condition
5. The investigative outcome of the treatment should not interfere with any trials that could support a medical's product development or marketing approval for the treatment indicated.
Explanation:
